MOUNTAIN VIEW, Calif., May 9, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the first and only proven non-incisional permanent birth control method available, announced today that company management is planning to participate in the following investor conferences:
